51.81 USD
↘ 1.43 (2.69%)AT CLOSE (11:59 AM EDT)
BioMarin Pharmaceuticals Inc
BMRNNASDAQ • USD
52.30
↗ 0.49 (0.95%)
POST MARKET (AS OF 07:04 PM EDT)
Post Market
AS OF 07:04 PM EDT
52.30
↗ 0.49 (0.95%)
Market: CLOSED
Open?$53.41
High?$53.41
Low?$51.68
Prev. Close?$53.24
Volume?2.1M
Avg. Volume?1.7M
VWAP?$52.21
Rel. Volume?1.21x
Bid / Ask
Bid?$49.75 × 100
Ask?$55.32 × 100
Spread?$5.57
Midpoint?$52.54
Valuation & Ratios
Market Cap?10.0B
Shares Out?193.3M
Float?190.5M
Float %?99.2%
P/E Ratio?37.26
P/B Ratio?1.61
EPS?$1.39
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Themes
Employees
3.2K
Market Cap
10.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1999-07-23
Address
105 DIGITAL DRIVE
NOVATO, CA 94949
Phone: (415) 506-6700
NOVATO, CA 94949
Phone: (415) 506-6700
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.81Strong
Quick Ratio?4.20Strong
Cash Ratio?2.80Strong
Debt/Equity?0.23Low
ValuationFAIRLY VALUED
Score72/100
P/E?37.3PRICEY▾
P/B?1.61CHEAP▾
P/S?3.09FAIR▾
P/FCF?13.1CHEAP▾
EV/EBITDA?23.7HIGH▾
EV/Sales?2.84CHEAP▾
Returns & Efficiency
ROE?4.3%WEAK▾
ROA?3.1%FAIR▾
Cash Flow & Enterprise
FCF?$767.1M
Enterprise Value?$9.2B
Fundamentals ratios updated end of day